About Numiera Therapeutics Numiera is a preclinical-stage pharmaceutical company focused on developing small-molecule ...

By adding Canada and the entire Latin America region, including Mexico, WODA completes its full global commercialization offering for rare and specialty therapies.With two new members - Innovative ...

Confirmation that the ongoing DIAGNODE-3 Phase 3 trial aligns with requirements for an Accelerated Approval, leveraging interim efficacy data based on stimulated C-peptide as the primary endpoint from ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...

Numiera Therapeutics Inc., a client company of Fort Collins-based Innosphere and a pharmaceutical pioneer in small-molecule ...

A subsidiary of a Miami-based company is inching closer to FDA approval for a drug that treats a rare pediatric disease.

From established players to up-and-coming firms, Canada's pharmaceutical company landscape is diverse and dynamic. Canadian ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...

There has been a significant increase in orphanhood in the last two decades in the U.S., according to a new study. The ...